Last reviewed · How we verify

usual pain treatment

St. Olavs Hospital · Phase 3 active Small molecule

Blocks pain signals to the brain.

Blocks pain signals to the brain. Used for Moderate to severe pain, Severe pain.

At a glance

Generic nameusual pain treatment
SponsorSt. Olavs Hospital
Drug classopioid
ModalitySmall molecule
Therapeutic areaPain management
PhasePhase 3

Mechanism of action

This is achieved by inhibiting the action of pain neurotransmitters, such as substance P, at the level of the spinal cord and brain. The exact mechanism of action is not fully understood, but it is thought to involve the inhibition of voltage-gated sodium channels and the reduction of excitatory neurotransmitter release.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: